Results 11 to 20 of about 39,466 (197)
Application and interpretation of immunophenotyping data in safety and risk assessment [PDF]
Frontiers in ToxicologyThe use of immunophenotyping during immunotoxicity investigations was first popularized in the 1980 s and has since become more integrated into diagnostic and non-clinical assessments.
Victor J. Johnson +7 more
doaj +2 more sources
Carboxypeptidase A3—A Key Component of the Protease Phenotype of Mast Cells
Cells, 2022 Carboxypeptidase A3 (CPA3) is a specific mast cell (MC) protease with variable expression. This protease is one of the preformed components of the secretome.
Dmitri Atiakshin +5 more
doaj +1 more source
Pharmaceuticals, 2023 The mechanisms of regeneration for the fibrous component of the connective tissue of the dermis are still insufficiently studied. The aim of this study was to evaluate the effectiveness of the use of molecular hydrogen on the local therapy of a II degree
Dmitri Atiakshin +8 more
doaj +1 more source
Pharmaceuticals, 2023 Knowledge of the biological effects of molecular hydrogen (H2), hydrogen gas, is constantly advancing, giving a reason for the optimism in several healthcare practitioners regarding the management of multiple diseases, including socially significant ones
Dmitri Atiakshin +8 more
doaj +1 more source
The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders
British Journal of Biomedical Science, 2023 Background: B-Cell Lymphoproliferative Disorders (B-LPDs) are a group of heterogenous disorders characterised by the accumulation of B-cells in peripheral blood, bone marrow, lymph nodes and spleen.
Hanaan Kareem Al-Zubaidi +1 more
doaj +1 more source
Frontiers in Oncology, 2020 Undetectable minimal residual disease (MRD) in Chronic Lymphocytic Leukemia (CLL) has a favorable prognostic outcome compared with MRD that can be detected.
Timothy W. Farren +4 more
doaj +1 more source
Frontiers in Immunology, 2021 The treatment of chronic inflammatory and degenerative diseases by low dose radiation therapy (LDRT) is promising especially for patients who were refractory for classical therapies.
Anna-Jasmina Donaubauer +16 more
doaj +1 more source
An Unusual Case of Primary Plasma Cell Leukaemia Mimicking Acute Leukaemia: A Case Report and Review of Literature [PDF]
Journal of Clinical and Diagnostic Research, 2017 Plasma Cell Leukaemia (PCL) is rare and an aggressive disease accounting for only 2-3% of all plasma cell dyscrasias. Diagnosis is made when there are more than 2x109 /L plasma cells in the peripheral blood or monoclonal plasmacytosis more than 20% of
Abha Singla, Monica Gupta
doaj +1 more source
From Conventional to Precision Therapy in Canine Mammary Cancer: A Comprehensive Review
Frontiers in Veterinary Science, 2021 Canine mammary tumors (CMTs) are the most common neoplasm in intact female dogs. Canine mammary cancer (CMC) represents 50% of CMTs, and besides surgery, which is the elective treatment, additional targeted and non-targeted therapies could offer benefits
Guillermo Valdivia +7 more
doaj +1 more source
Frontiers in Immunology, 2021 Immunotherapies are revolutionizing cancer treatment by boosting the natural ability of the immune system. In addition to antibodies against traditional checkpoint molecules or their ligands (i.e., CTLA-4, PD-1, and PD-L1), therapies targeting molecules ...
Darci Phillips +8 more
doaj +1 more source